EAM Investors’s Apyx Medical APYX Stock Holding History

EAM Investors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$765K	Sell	170,470 -75,965	-31%	-$301K	0.07%	250
2026 Q1	$909K	Hold	246,435	–	–	0.11%	218
2025 Q4	$863K	Buy	+246,435	New	+$859K	0.1%	221
2023 Q3	–	Sell	-251,896	Closed	-$1.27M	–	280
2023 Q2	$1.27M	Buy	+251,896	New	+$1.28M	0.23%	196
2022 Q1	–	Sell	-208,852	Closed	-$2.68M	–	276
2021 Q4	$2.68M	Buy	208,852 +80,292	+62%	+$1.12M	0.44%	64
2021 Q3	$1.78M	Buy	+128,560	New	+$1.35M	0.3%	152
2021 Q2	–	Sell	-133,630	Closed	-$1.29M	–	314
2021 Q1	$1.29M	Buy	+133,630	New	+$1.34M	0.19%	256
2020 Q3	–	Sell	-144,224	Closed	-$800K	–	272
2020 Q2	$800K	Buy	+144,224	New	+$599K	0.18%	214
2019 Q2	–	Sell	-218,870	Closed	-$1.38M	–	253
2019 Q1	$1.38M	Sell	218,870 -131,645	-38%	-$1.02M	0.34%	137
2018 Q4	$2.27M	Buy	350,515 +51,475	+17%	+$312K	0.62%	35
2018 Q3	$2.12M	Buy	+299,040	New	+$1.66M	0.32%	148
2017 Q1	–	Sell	-298,666	Closed	-$1.07M	–	313
2016 Q4	$1.07M	Sell	298,666 -111,602	-27%	-$497K	0.14%	253
2016 Q3	$2.14M	Buy	+410,268	New	+$1.33M	0.29%	183

Other funds holding APYX

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM Investors's APYX Position: Q2 2026 in Review

EAM Investors reduced its Apyx Medical (APYX) stake by 31% in Q2 2026, selling an estimated $301K and leaving 170,470 shares worth $765K. The position accounts for 0.07% of the portfolio, ranked #250.

EAM Investors first reported a position in APYX in Q3 2016 and has held it in 13 quarters since. The position peaked at $2.68M in Q4 2021. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

EAM Investors held 170,470 shares of Apyx Medical worth $765K as of Q2 2026.
EAM Investors sold 75,965 Apyx Medical shares in Q2 2026, an estimated $301K.
Apyx Medical made up 0.07% of EAM Investors's portfolio in Q2 2026, its #250 holding.
EAM Investors first reported a position in Apyx Medical in Q3 2016 and has held it in 13 quarters since.
EAM Investors's Apyx Medical position peaked at $2.68M in Q4 2021.
68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.